Gabapentin in Patients at Clinical Risk for Psychosis

Summary

The purpose of this study is to test the effects of the drug gabapentin on brain function thought to be important in the development of schizophrenia. Researchers think that treating a brain region with gabapentin (the hippocampus) may reduce the risk for developing schizophrenia.

Timeline

Start

2015-08-01

Primary completion

2016-06-12

Completion

2016-06-12

Outcome

Outcome not reported

Stopped (Business): “Combination of insufficient funding and lack of compelling findings”

Drugs

Indications